Inventor
GREEN COLIN RICHARD
NZ22 patents
⚠️ This page may combine multiple inventors who share the name “GREEN COLIN RICHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CODA THERAPEUTICS INC
9 patentsUS7919474B2Apr 5, 2011
Formulations comprising antisense nucleotides to connexins
CODA THERAPEUTICS INC13 citations91
US7902164B2Mar 8, 2011
Formulations comprising antisense nucleotides to connexins
CODA THERAPEUTICS INC10 citations91
US9738892B2Aug 22, 2017
Treatment of fibrotic conditions
CODA THERAPEUTICS INC2 citations70
US9561311B2Feb 7, 2017
Medical devices
CODA THERAPEUTICS INC1 citations59
US10174316B2Jan 8, 2019
Anti-connexin compounds targeted to connexins and methods of use thereof
CODA THERAPEUTICS INC0 citations50
US10201590B2Feb 12, 2019
Treatment of ocular disorders with anti-connexin proteins and mimetics
CODA THERAPEUTICS INC0 citations49
US9932592B2Apr 3, 2018
Formulations comprising antisense nucleotides to connexins
CODA THERAPEUTICS INC0 citations49
US9637745B2May 2, 2017
Impaired wound healing compositions and treatments
CODA THERAPEUTICS INC0 citations49
US9193754B2Nov 24, 2015
Formulations comprising antisense nucleotides to connexins
CODA THERAPEUTICS INC0 citations49
AUCKLAND UNISERVICES LTD
4 patentsUS10465188B2Nov 5, 2019
Channel modulators
AUCKLAND UNISERVICES LTD2 citations70
US11401516B2Aug 2, 2022
Channel modulators
AUCKLAND UNISERVICES LTD0 citations59
US11466069B2Oct 11, 2022
Methods of treatment and novel constructs
AUCKLAND UNISERVICES LTD0 citations49
US11344603B2May 31, 2022
Cytokine modulation
AUCKLAND UNISERVICES LTD0 citations43
BECKER DAVID LAURENCE
3 patentsUS8314074B2Nov 20, 2012
Formulations comprising antisense nucleotides to connexins
BECKER DAVID LAURENCE3 citations71
US8685940B2Apr 1, 2014
Impaired wound healing compositions and treatments
BECKER DAVID LAURENCE1 citations59
US9029339B2May 12, 2015
Impaired wound healing compositions and methods
BECKER DAVID LAURENCE0 citations48
OCUNEXUS THERAPEUTICS INC
3 patentsUS11390870B2Jul 19, 2022
Anti-connexin compounds targeted to connexins and methods of use thereof
OCUNEXUS THERAPEUTICS INC0 citations59
US10787667B2Sep 29, 2020
Anti-connexin compounds targeted to connexins and methods of use thereof
OCUNEXUS THERAPEUTICS INC0 citations48
US10472632B2Nov 12, 2019
Anti-connexin compounds targeted to connexins and methods of use thereof
OCUNEXUS THERAPEUTICS INC0 citations48